Scarica l'app Stockscreener
8.39
1.99%
-0.17
Dopo l'orario di chiusura:
8.24
-0.15
-1.79%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Precedente Chiudi:
$8.56
Aprire:
$8.52
Volume 24 ore:
1.00M
Relative Volume:
0.71
Capitalizzazione di mercato:
$1.31B
Reddito:
$53.61M
Utile/perdita netta:
$-142.52M
Rapporto P/E:
-7.5586
EPS:
-1.11
Flusso di cassa netto:
$-141.83M
1 W Prestazione:
+4.74%
1M Prestazione:
+22.84%
6M Prestazione:
-30.14%
1 anno Prestazione:
+36.42%
Intervallo 1D:
$8.325
$8.58
Intervallo di 1 settimana:
$7.69
$8.73
Portata 52W:
$5.04
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Nome
Wave Life Sciences Ltd
Settore
Industria
Telefono
617-949-2900
Indirizzo
7 STRAITS VIEW, SINGAPORE
Confronta WVE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
8.39 | 1.33B | 53.61M | -142.52M | -141.83M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-16 | Iniziato | Citigroup | Buy |
| 2025-06-11 | Ripresa | Raymond James | Outperform |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Iniziato | Wedbush | Outperform |
| 2025-02-25 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Ripresa | JP Morgan | Overweight |
| 2024-09-19 | Iniziato | B. Riley Securities | Buy |
| 2024-09-09 | Iniziato | JP Morgan | Overweight |
| 2024-05-15 | Iniziato | Wells Fargo | Overweight |
| 2023-12-19 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Iniziato | Raymond James | Outperform |
| 2023-05-24 | Downgrade | Jefferies | Buy → Hold |
| 2020-12-15 | Ripresa | H.C. Wainwright | Buy |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Iniziato | Guggenheim | Buy |
| 2019-07-15 | Iniziato | Cowen | Market Perform |
| 2019-04-17 | Reiterato | H.C. Wainwright | Buy |
| 2018-08-07 | Iniziato | Stifel | Buy |
| 2018-07-23 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-19 | Reiterato | Mizuho | Buy |
| 2017-02-15 | Iniziato | H.C. Wainwright | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-12-07 | Iniziato | Jefferies | Buy |
| 2015-12-07 | Iniziato | Leerink Partners | Outperform |
| 2015-12-07 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
What risks could impact Wave Life Sciences Ltd. stock performanceConsistently exceptional gains - jammulinksnews.com
Is Wave Life Sciences Ltd. a good long term investmentLightning-fast growth - Autocar Professional
Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 - GlobeNewswire
Wave Life Sciences to Host Webcast for Q2 2025 Financial Results and Business Updates - Quiver Quantitative
Why Wave Life Sciences Ltd. stock attracts strong analyst attentionFree Join Group - Newser
What analysts say about Wave Life Sciences Ltd. stockRemarkably fast returns - jammulinksnews.com
What drives Wave Life Sciences Ltd. stock priceFree Investment Portfolio Suggestions - jammulinksnews.com
Wave Life Sciences Ltd. Stock Analysis and ForecastAccelerated financial growth - Autocar Professional
(WVE) Investment Analysis - news.stocktradersdaily.com
WAVE Life Sciences (NASDAQ:WVE) Research Coverage Started at Citigroup - Defense World
Will WAVE's Q1 2025 forecast meet expectations? - AInvest
When is the best time to buy Wave Life Sciences Ltd. stockReturn Maximized Portfolio Strategy - Newser
WAVE Life Sciences Receives Buy Rating and USD 16 Price Target from Citigroup - AInvest
Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions - MSN
Wave Life Sciences’ SWOT analysis: RNA editing stock poised for breakthrough - Investing.com Australia
Jessica Chen - White & Case LLP
Breaking Down WAVE Life Sciences: 4 Analysts Share Their Views - Benzinga
Citi initiates coverage on WAVE Life Sciences stock with Buy rating - Investing.com Australia
Citi initiates coverage on WAVE Life Sciences stock with Buy rating By Investing.com - Investing.com South Africa
What makes Wave Life Sciences Ltd. stock price move sharplyFree Stock Index Interpretation - Newser
13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey
Leerink Partners Reiterates a Buy Rating on Wave Life Sciences (WVE), Keeps the PT at $24 - Yahoo Finance
Wave Life Sciences stock reiterated Overweight by Cantor Fitzgerald - Investing.com South Africa
How the (WVE) price action is used to our Advantage - news.stocktradersdaily.com
Huntington's Disease Pipeline 2025: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight Spark Therapeutics, Chong Kun Dang Pharma, Neuvivo, Uniqure Biopharma, Wave Life Sciences, Novartis - Menafn.com
Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months (NASDAQ:WVE) - Seeking Alpha
We Think Wave Life Sciences (NASDAQ:WVE) Needs To Drive Business Growth Carefully - simplywall.st
Wave Life Sciences: Speculative, But Promising (NASDAQ:WVE) - Seeking Alpha
H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release - Insider Monkey
Wave Life Sciences’ SWOT analysis: RNA editing stock faces fierce competition - Investing.com
WVE: Wedbush Reiterates Outperform Rating on WAVE Life Sciences | WVE Stock News - GuruFocus
Wave Life sciences stock rating reiterated by Cantor Fitzgerald - Investing.com India
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions - The Manila Times
Wave Life Sciences reports promising obesity treatment data By Investing.com - Investing.com Nigeria
Wave Life Sciences’s SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Canada
Wave Life Sciences Ltd Azioni (WVE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):